| Dec 11, 2025 |
Dec 15, 2025 |
Climb Bio, Inc.
|
Director |
Buy |
20.0
|
-20,125,439
|
-85.56%
|
✗
|
$754.7K |
| Nov 20, 2025 |
Nov 24, 2025 |
Sionna Therapeutics, Inc.
|
Director |
Sell |
42.5
|
-30,316
|
-0.10%
|
✗
|
$1.2M |
| Nov 17, 2025 |
Nov 19, 2025 |
Sionna Therapeutics, Inc.
|
Director |
Sell |
33.8
|
-136,351
|
-0.23%
|
✗
|
$5.5M |
| Oct 24, 2025 |
Oct 28, 2025 |
Sionna Therapeutics, Inc.
|
Director |
Sell |
15.0
|
-373,610
|
-1.82%
|
✗
|
$14.8M |
| Sep 4, 2025 |
Sep 8, 2025 |
Mineralys Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+1,176,470
|
27.49%
|
✗
|
$30M |
| Mar 13, 2025 |
Mar 17, 2025 |
Mineralys Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+1,296,296
|
43.45%
|
✗
|
$17.5M |
| Feb 10, 2025 |
Feb 10, 2025 |
Sionna Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+1,125,000
|
13.85%
|
✗
|
$20.3M |
| Oct 28, 2024 |
Oct 30, 2024 |
Septerna, Inc.
|
Director |
Buy |
100.0
|
+4,170,000
|
147.57%
|
✗
|
$75.1M |
| Sep 16, 2024 |
Sep 18, 2024 |
Bicara Therapeutics Inc.
|
Director |
Buy |
100.0
|
+1,833,000
|
35.78%
|
✗
|
$33M |
| Jul 22, 2024 |
Jul 24, 2024 |
Artiva Biotherapeutics, Inc.
|
Director |
Buy |
100.0
|
+8,795,020
|
459.88%
|
✗
|
$104.7M |
| Jun 27, 2024 |
Jul 1, 2024 |
Climb Bio, Inc.
|
Director |
Buy |
100.0
|
+18,268,418
|
76.18%
|
✗
|
$50M |
| Feb 14, 2023 |
Feb 16, 2023 |
Mineralys Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+1,250,000
|
64.82%
|
✗
|
$20M |